The SVP CIO of Laboratory Corp (LH) is Selling Shares


Today, the SVP CIO of Laboratory Corp (NYSE: LH), Lance Berberian, sold shares of LH for $1M.

Following Lance Berberian’s last LH Sell transaction on May 24, 2017, the stock climbed by 41.7%. In addition to Lance Berberian, 3 other LH executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Laboratory Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $2.85 billion and quarterly net profit of $173 million. In comparison, last year the company earned revenue of $2.45 billion and had a net profit of $192 million. LH’s market cap is $18.63B and the company has a P/E ratio of 15.14. Currently, Laboratory Corp has an average volume of 498.3K.

Based on 6 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $197.20, reflecting a -7.2% downside.

The insider sentiment on Laboratory Corp has been negative according to 60 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts